Track: Advances and Latest trends on diabetic research

Diabetes 2026

Session Overview

This session provides an in-depth look at the latest scientific breakthroughs and research directions in diabetes. It focuses on how new discoveries are shaping the future of diabetes care, including early detection, individualized treatment strategies, and prevention programs.


Key Topics

Genomics and Biomarkers in Diabetes: Advances in genetic research and biomarker discovery are helping identify individuals at risk for diabetes and improving disease classification and prognosis.


Precision Medicine and Personalized Care: Personalized treatment strategies based on genetic, metabolic, and lifestyle factors can improve clinical outcomes and reduce the risk of complications.


Digital Health and Artificial Intelligence: AI-powered tools, mobile apps, and wearable devices are increasingly used for continuous glucose monitoring, patient engagement, and predictive analytics.


Novel Therapeutic Targets: Research is identifying new molecular targets for drug development, including pathways related to inflammation, metabolism, and beta-cell protection.


Translational and Clinical Research: Translational research bridges laboratory discoveries with clinical applications, supporting the development of new therapies and improved care models.


Learning Objectives

The session aims to enhance understanding of precision medicine, digital health tools, and novel therapeutic approaches. Attendees will be able to evaluate how emerging technologies and biomarkers can improve diabetes diagnosis and management. The session also emphasizes the importance of translational research in bringing new discoveries into clinical practice.